TY - JOUR AU - Doughty, J. C. PY - 2008 DA - 2008// TI - A review of the BIG results: the Breast International Group 1-98 trial analyses JO - Breast VL - 17 UR - https://doi.org/10.1016/S0960-9776(08)70003-1 DO - 10.1016/S0960-9776(08)70003-1 ID - Doughty2008 ER - TY - STD TI - Johnston SR. Enhancing endocrine therapy for hormone receptor-positive advanced breast cancer: cotargeting signaling pathways. J Natl Cancer Inst. 2015;107(10). doi: https://doi.org/10.1093/jnci/djv212. ID - ref2 ER - TY - JOUR AU - McIlroy, M. AU - McCartan, D. AU - Early, S. AU - O Gaora, P. AU - Pennington, S. AU - Hill, A. D. AU - Young, L. S. PY - 2010 DA - 2010// TI - Interaction of developmental transcription factor HOXC11 with steroid receptor coactivator SRC-1 mediates resistance to endocrine therapy in breast cancer JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-3713 DO - 10.1158/0008-5472.CAN-09-3713 ID - McIlroy2010 ER - TY - JOUR AU - deBlacam, C. AU - Byrne, C. AU - Hughes, E. AU - McIlroy, M. AU - Bane, F. AU - Hill, A. D. AU - Young, L. S. PY - 2011 DA - 2011// TI - HOXC11-SRC-1 regulation of S100beta in cutaneous melanoma: new targets for the kinase inhibitor dasatinib JO - Br J Cancer VL - 105( UR - https://doi.org/10.1038/bjc.2011.193 DO - 10.1038/bjc.2011.193 ID - deBlacam2011 ER - TY - JOUR AU - Walsh, C. A. AU - Qin, L. AU - Tien, J. AU - Young, L. S. AU - Xu, J. PY - 2012 DA - 2012// TI - The function of steroid receptor coactivator-1 in normal tissues and cancer JO - Int J Biol Sci VL - 8 UR - https://doi.org/10.7150/ijbs.4125 DO - 10.7150/ijbs.4125 ID - Walsh2012 ER - TY - JOUR AU - Zhang, X. AU - Hamada, J. AU - Nishimoto, A. AU - Takahashi, Y. AU - Murai, T. AU - Tada, M. AU - Moriuchi, T. PY - 2007 DA - 2007// TI - HOXC6 and HOXC11 increase transcription of S100beta gene in BrdU-induced in vitro differentiation of GOTO neuroblastoma cells into Schwannian cells JO - J Cell Mol Med VL - 11 UR - https://doi.org/10.1111/j.1582-4934.2007.00020.x DO - 10.1111/j.1582-4934.2007.00020.x ID - Zhang2007 ER - TY - JOUR AU - Jiang, W. G. AU - Watkins, G. AU - Douglas-Jones, A. AU - Mansel, R. E. PY - 2004 DA - 2004// TI - Psoriasin is aberrantly expressed in human breast cancer and is related to clinical outcomes JO - Int J Oncol VL - 25 ID - Jiang2004 ER - TY - JOUR AU - Zhao, H. AU - Wilkie, T. AU - Deol, Y. AU - Sneh, A. AU - Ganju, A. AU - Basree, M. AU - Nasser, M. W. AU - Ganju, R. K. PY - 2015 DA - 2015// TI - miR-29b defines the pro-/anti-proliferative effects of S100A7 in breast cancer JO - Mol Cancer VL - 14 UR - https://doi.org/10.1186/s12943-014-0275-z DO - 10.1186/s12943-014-0275-z ID - Zhao2015 ER - TY - JOUR AU - Chung, L. AU - Phillips, L. AU - Lin, M. Z. AU - Moore, K. AU - Marsh, D. J. AU - Boyle, F. M. AU - Baxter, R. C. PY - 2015 DA - 2015// TI - A novel truncated form of S100P predicts disease-free survival in patients with lymph node positive breast cancer JO - Cancer Lett VL - 368 UR - https://doi.org/10.1016/j.canlet.2015.07.046 DO - 10.1016/j.canlet.2015.07.046 ID - Chung2015 ER - TY - JOUR AU - Gebhardt, C. AU - Lichtenberger, R. AU - Utikal, J. PY - 2016 DA - 2016// TI - Biomarker value and pitfalls of serum S100B in the follow-up of high-risk melanoma patients JO - J Dtsch Dermatol Ges VL - 14 ID - Gebhardt2016 ER - TY - JOUR AU - Sedaghat, F. AU - Notopoulos, A. PY - 2008 DA - 2008// TI - S100 protein family and its application in clinical practice JO - Hippokratia VL - 12 ID - Sedaghat2008 ER - TY - JOUR AU - Donato, R. AU - Cannon, B. R. AU - Sorci, G. AU - Riuzzi, F. AU - Hsu, K. AU - Weber, D. J. AU - Geczy, C. L. PY - 2013 DA - 2013// TI - Functions of S100 proteins JO - Curr Mol Med VL - 13 UR - https://doi.org/10.2174/156652413804486214 DO - 10.2174/156652413804486214 ID - Donato2013 ER - TY - JOUR AU - Massarweh, S. AU - Schiff, R. PY - 2006 DA - 2006// TI - Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk JO - Endocr Relat Cancer VL - 13 UR - https://doi.org/10.1677/erc.1.01273 DO - 10.1677/erc.1.01273 ID - Massarweh2006 ER - TY - JOUR AU - Sen, B. AU - Johnson, F. M. PY - 2011 DA - 2011// TI - Regulation of SRC family kinases in human cancers JO - J Signal Transduct VL - 2011 UR - https://doi.org/10.1155/2011/865819 DO - 10.1155/2011/865819 ID - Sen2011 ER - TY - JOUR AU - Shah, Y. M. AU - Rowan, B. G. PY - 2005 DA - 2005// TI - The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity JO - Mol Endocrinol VL - 19 UR - https://doi.org/10.1210/me.2004-0298 DO - 10.1210/me.2004-0298 ID - Shah2005 ER - TY - JOUR AU - Eustace, A. J. AU - Crown, J. AU - Clynes, M. AU - O’Donovan, N. PY - 2008 DA - 2008// TI - Preclinical evaluation of dasatinib, a potent Src kinase inhibitor, in melanoma cell lines JO - J Transl Med VL - 6 UR - https://doi.org/10.1186/1479-5876-6-53 DO - 10.1186/1479-5876-6-53 ID - Eustace2008 ER - TY - JOUR AU - Finn, R. S. AU - Bengala, C. AU - Ibrahim, N. AU - Roche, H. AU - Sparano, J. AU - Strauss, L. C. AU - Fairchild, J. AU - Sy, O. AU - Goldstein, L. J. PY - 2011 DA - 2011// TI - Dasatinib as a single agent in triple-negative breast cancer: results of an open-label phase 2 study JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0288 DO - 10.1158/1078-0432.CCR-11-0288 ID - Finn2011 ER - TY - JOUR AU - Mayer, E. L. AU - Baurain, J. F. AU - Sparano, J. AU - Strauss, L. AU - Campone, M. AU - Fumoleau, P. AU - Rugo, H. AU - Awada, A. AU - Sy, O. AU - Llombart-Cussac, A. PY - 2011 DA - 2011// TI - A phase 2 trial of dasatinib in patients with advanced HER2-positive and/or hormone receptor-positive breast cancer JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0070 DO - 10.1158/1078-0432.CCR-11-0070 ID - Mayer2011 ER - TY - JOUR AU - Pusztai, L. AU - Moulder, S. AU - Altan, M. AU - Kwiatkowski, D. AU - Valero, V. AU - Ueno, N. T. AU - Esteva, F. J. AU - Avritscher, R. AU - Qi, Y. AU - Strauss, L. PY - 2014 DA - 2014// TI - Gene signature-guided dasatinib therapy in metastatic breast cancer JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-14-0800 DO - 10.1158/1078-0432.CCR-14-0800 ID - Pusztai2014 ER - TY - JOUR AU - McShane, L. M. AU - Altman, D. G. AU - Sauerbrei, W. AU - Taube, S. E. AU - Gion, M. AU - Clark, G. M. PY - 2005 DA - 2005// TI - Statistics Subcommittee of the NCIEWGoCD: REporting recommendations for tumour MARKer prognostic studies (REMARK) JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602678 DO - 10.1038/sj.bjc.6602678 ID - McShane2005 ER - TY - JOUR AU - Dillon, M. F. AU - Stafford, A. T. AU - Kelly, G. AU - Redmond, A. M. AU - McIlroy, M. AU - Crotty, T. B. AU - McDermott, E. AU - Hill, A. D. AU - Young, L. S. PY - 2008 DA - 2008// TI - Cyclooxygenase-2 predicts adverse effects of tamoxifen: a possible mechanism of role for nuclear HER2 in breast cancer patients JO - Endocr Relat Cancer VL - 15 UR - https://doi.org/10.1677/ERC-08-0009 DO - 10.1677/ERC-08-0009 ID - Dillon2008 ER - TY - JOUR AU - Centenera, M. M. AU - Gillis, J. L. AU - Hanson, A. R. AU - Jindal, S. AU - Taylor, R. A. AU - Risbridger, G. P. AU - Sutherland, P. D. AU - Scher, H. I. AU - Raj, G. V. AU - Knudsen, K. E. PY - 2012 DA - 2012// TI - Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumors JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0782 DO - 10.1158/1078-0432.CCR-12-0782 ID - Centenera2012 ER - TY - JOUR AU - McCartan, D. AU - Bolger, J. C. AU - Fagan, A. AU - Byrne, C. AU - Hao, Y. AU - Qin, L. AU - McIlroy, M. AU - Xu, J. AU - Hill, A. D. AU - Gaora, P. PY - 2012 DA - 2012// TI - Global characterization of the SRC-1 transcriptome identifies ADAM22 as an ER-independent mediator of endocrine-resistant breast cancer JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-1976 DO - 10.1158/0008-5472.CAN-11-1976 ID - McCartan2012 ER - TY - JOUR AU - Bronzert, D. A. AU - Greene, G. L. AU - Lippman, M. E. PY - 1985 DA - 1985// TI - Selection and characterization of a breast cancer cell line resistant to the antiestrogen LY 117018 JO - Endocrinology VL - 117 UR - https://doi.org/10.1210/endo-117-4-1409 DO - 10.1210/endo-117-4-1409 ID - Bronzert1985 ER - TY - JOUR AU - Redmond, A. M. AU - Bane, F. T. AU - Stafford, A. T. AU - McIlroy, M. AU - Dillon, M. F. AU - Crotty, T. B. AU - Hill, A. D. AU - Young, L. S. PY - 2009 DA - 2009// TI - Coassociation of estrogen receptor and p160 proteins predicts resistance to endocrine treatment; SRC-1 is an independent predictor of breast cancer recurrence JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-1649 DO - 10.1158/1078-0432.CCR-08-1649 ID - Redmond2009 ER - TY - JOUR AU - McBryan, J. AU - Fagan, A. AU - McCartan, D. AU - Bane, F. T. AU - Vareslija, D. AU - Cocchiglia, S. AU - Byrne, C. AU - Bolger, J. AU - McIlroy, M. AU - Hudson, L. PY - 2015 DA - 2015// TI - Transcriptomic profiling of sequential tumors from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy JO - Clin Cancer Res VL - 21 UR - https://doi.org/10.1158/1078-0432.CCR-14-2155 DO - 10.1158/1078-0432.CCR-14-2155 ID - McBryan2015 ER - TY - JOUR AU - Filipits, M. AU - Rudas, M. AU - Jakesz, R. AU - Dubsky, P. AU - Fitzal, F. AU - Singer, C. F. AU - Dietze, O. AU - Greil, R. AU - Jelen, A. AU - Sevelda, P. PY - 2011 DA - 2011// TI - A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0926 DO - 10.1158/1078-0432.CCR-11-0926 ID - Filipits2011 ER - TY - JOUR AU - Parker, J. S. AU - Mullins, M. AU - Cheang, M. C. AU - Leung, S. AU - Voduc, D. AU - Vickery, T. AU - Davies, S. AU - Fauron, C. AU - He, X. AU - Hu, Z. PY - 2009 DA - 2009// TI - Supervised risk predictor of breast cancer based on intrinsic subtypes JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.18.1370 DO - 10.1200/JCO.2008.18.1370 ID - Parker2009 ER - TY - JOUR AU - Nielsen, T. O. AU - Parker, J. S. AU - Leung, S. AU - Voduc, D. AU - Ebbert, M. AU - Vickery, T. AU - Davies, S. R. AU - Snider, J. AU - Stijleman, I. J. AU - Reed, J. PY - 2010 DA - 2010// TI - A comparison of PAM50 intrinsic subtyping with immunohistochemistry and clinical prognostic factors in tamoxifen-treated estrogen receptor-positive breast cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-10-1282 DO - 10.1158/1078-0432.CCR-10-1282 ID - Nielsen2010 ER - TY - JOUR AU - Koren, S. AU - Bentires-Alj, M. PY - 2015 DA - 2015// TI - Breast tumor heterogeneity: source of fitness, hurdle for therapy JO - Mol Cell VL - 60 UR - https://doi.org/10.1016/j.molcel.2015.10.031 DO - 10.1016/j.molcel.2015.10.031 ID - Koren2015 ER - TY - JOUR AU - Saunus, J. M. AU - Quinn, M. C. AU - Patch, A. M. AU - Pearson, J. V. AU - Bailey, P. J. AU - Nones, K. AU - McCart Reed, A. E. AU - Miller, D. AU - Wilson, P. J. AU - Al-Ejeh, F. PY - 2015 DA - 2015// TI - Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance JO - J Pathol VL - 237 UR - https://doi.org/10.1002/path.4583 DO - 10.1002/path.4583 ID - Saunus2015 ER - TY - JOUR AU - Blessing, E. M. AU - Steenkamp, M. M. AU - Manzanares, J. AU - Marmar, C. R. PY - 2015 DA - 2015// TI - Cannabidiol as a potential treatment for anxiety disorders JO - Neurotherapeutics VL - 12 UR - https://doi.org/10.1007/s13311-015-0387-1 DO - 10.1007/s13311-015-0387-1 ID - Blessing2015 ER - TY - JOUR AU - Pathiraja, T. N. AU - Nayak, S. R. AU - Xi, Y. AU - Jiang, S. AU - Garee, J. P. AU - Edwards, D. P. AU - Lee, A. V. AU - Chen, J. AU - Shea, M. J. AU - Santen, R. J. PY - 2014 DA - 2014// TI - Epigenetic reprogramming of HOXC10 in endocrine-resistant breast cancer JO - Sci Transl Med VL - 6 UR - https://doi.org/10.1126/scitranslmed.3008326 DO - 10.1126/scitranslmed.3008326 ID - Pathiraja2014 ER - TY - JOUR AU - Daniel, A. R. AU - Hagan, C. R. AU - Lange, C. A. PY - 2011 DA - 2011// TI - Progesterone receptor action: defining a role in breast cancer JO - Expert Rev Endocrinol Metab VL - 6 UR - https://doi.org/10.1586/eem.11.25 DO - 10.1586/eem.11.25 ID - Daniel2011 ER - TY - JOUR AU - Ankerst, D. P. AU - Thompson, I. M. PY - 2006 DA - 2006// TI - Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification JO - Arch Ital Urol Androl VL - 78 ID - Ankerst2006 ER -